Apellis Pharmaceuticals (APLS) Appoints Craig Wheeler to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. ACCV
4. FLG
5. GMAB
6. QQQ
7. SPCX
8. AZN
9. APO
10. META

Go back to Apellis Pharmaceuticals (APLS) Appoints Craig Wheeler to its Board

Apellis Announces Craig Wheeler to Join the Board of Directors

April 21, 2025 7:00 AM EDT

WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that Craig Wheeler, founder and chief executive officer of Headwaters Biotech Advisors, will join the Apellis Board of Directors, effective immediately. Mr. Wheeler is a highly accomplished executive with more than 30 years of leadership experience across the biopharmaceutical industry.

We are thrilled to welcome Craig to the Apellis Board of Directors, said Cedric Francois, M.D., Ph.D., chief executive officer and co-founder, Apellis. Craig is a seasoned leader, who has successfully grown biopharmaceutical companies into strong commercial... More